{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:59:44Z","timestamp":1788724784462,"version":"build-2803163510"},"reference-count":67,"publisher":"Centers for Disease Control MMWR Office","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6907a1","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T10:28:21Z","timestamp":1596104901000},"page":"1-27","source":"Crossref","is-referenced-by-count":66,"title":["Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association"],"prefix":"10.15585","volume":"69","author":[{"given":"Barbara","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Will","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue C.","family":"Etkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Chorba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R1","article-title":"Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis.","volume":"44","author":"Advisory Council for the Elimination of Tuberculosis","year":"1995","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.15585\/mmwr.mm6911a3","article-title":"Tuberculosis\u2014United States, 2019.","volume":"69","author":"Schwartz","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R3","unstructured":"World Health Organization. WHO declares tuberculosis a global emergency. Geneva, Switzerland: World Health Organization; 1993."},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R4","unstructured":"World Health Organization. Towards TB elimination. An action framework for low-incidence countries. Geneva, Switzerland: World Health Organization; 2014. https:\/\/www.who.int\/tb\/publications\/elimination_framework\/en\/"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R5","unstructured":"CDC. Strategic planning for tuberculosis (TB) elimination in the United States and prevention and control of TB globally. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/stacks.cdc.gov\/view\/cdc\/13226\/Share"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R6","unstructured":"US Agency for International Development. National action plan for combating multidrug-resistant tuberculosis. Washington, DC: US Agency for International Development; 2019.\n                      \n                      https:\/\/www.usaid.gov\/global-health\/health-areas\/tuberculosis\/technical-areas\/national-action-plan-combating-mdr"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R7","unstructured":"Institute of Medicine. The future of public health. Washington, DC: The National Academies Press; 1988.\n                      \n                      https:\/\/www.nap.edu\/catalog\/1091\/the-future-of-public-health"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.puhe.2004.03.002","article-title":"Health departments\u2019 implementation of public health\u2019s core functions: an assessment of health impacts.","volume":"119","author":"Ford","year":"2005","journal-title":"Public Health"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1748-720X.1993.tb01255.x","article-title":"The resurgence of tuberculosis in the United States: societal origins and societal responses.","volume":"21","author":"Sidel","year":"1993","journal-title":"J Law Med Ethics"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R10","first-page":"83","article-title":"Resurgence of tuberculosis: the perspective a dozen years later.","volume":"7","author":"Kamholz","year":"1996","journal-title":"J Assoc Acad Minor Phys"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R11","unstructured":"Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: The National Academies Press; 2000. https:\/\/www.nap.edu\/catalog\/9837\/ending-neglect-the-elimination-of-tuberculosis-in-the-united-states"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R12","unstructured":"CDC. Funding opportunity announcement. Tuberculosis elimination and laboratory cooperative agreement CDC-RFA-PS20\u20132001. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/tb\/education\/funding-opportunity-notice.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R13","unstructured":"CDC; Center for State, Tribal, Local, and Territorial Support. National public health performance standards. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/publichealthgateway\/nphps\/index.html"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R14","unstructured":"CDC. Tuberculosis. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/tb\/"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R15","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R16","unstructured":"National Tuberculosis Controllers Association; Association of Public Health Laboratories. Consensus statement on the use of Cepheid Xpert MTB\/RIF\n                      \u00ae\n                      assay in making decisions to discontinue airborne infection isolation in healthcare settings. Smyrna, GA: National Tuberculosis Controllers Association. http:\/\/www.tbcontrollers.org\/resources\/airborne-infection-isolation\/#.W19aWdhKhmw"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1164\/ajrccm\/144.4.745","article-title":"Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.","volume":"144","author":"Brudney","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R18","unstructured":"CDC. Forging partnerships to eliminate tuberculosis. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. https:\/\/www.cdc.gov\/tb\/publications\/guidestoolkits\/forge\/ForgingPartnerships.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R19","unstructured":"Hodge JG Jr, Anderson E, Nelson G, Larson M. Tuberculosis control laws and policies: a handbook for public health and legal practitioners. Atlanta, GA: CDC; 2009. https:\/\/www.cdc.gov\/tb\/programs\/TBlawPolicyHandbook.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R20","unstructured":"Stop TB Partnership [Internet]. Geneva, Switzerland: United Nations Office for Project Services (UNOPS). http:\/\/www.stoptb.org\/"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R21","unstructured":"CDC. Report of verified case of tuberculosis (RVCT): instruction manual. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. https:\/\/www.cdc.gov\/tb\/programs\/rvct\/default.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R22","unstructured":"CDC. Reported tuberculosis in the United States, 2018. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2018\/default.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R23","unstructured":"National Tuberculosis Controllers Association. Interjurisdictional transfer form. Smyrna, GA: National Tuberculosis Controllers Association; 2015. http:\/\/www.tbcontrollers.org\/docs\/resources\/IJN_Form_May2015.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R24","unstructured":"CDC; Council of State and Territorial Epidemiologists. Latent TB infection (TB infection) 2018 case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/wwwn.cdc.gov\/nndss\/conditions\/latenttb\/case-definition\/2018\/"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R25","unstructured":"CDC. Guidelines for pre-departure and post-arrival medical screening and treatment of U.S.-bound refugees. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. https:\/\/www.cdc.gov\/immigrantrefugeehealth\/guidelines\/refugee-guidelines.html"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R26","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: U.S. Preventive Services Task Force recommendation statement.","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R27","unstructured":"CDC. Tuberculosis: data and statistics. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/tb\/statistics\/default.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R28","unstructured":"CDC. Fact sheet: National Tuberculosis Indicators Project (NTIP). Atlanta, GA: US Department of Health and Human Services, CDC; 2012. https:\/\/www.cdc.gov\/tb\/publications\/factsheets\/statistics\/ntip.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R29","unstructured":"CDC. Aggregate reports for tuberculosis program evaluation: training manual and user\u2019s guide. Atlanta, GA: US Department of Health and Human Services, CDC; 2005. https:\/\/www.cdc.gov\/tb\/publications\/pdf\/arpes_manualsm1.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R30","article-title":"Disease surveillance among newly arriving refugees and immigrants\u2014Electronic Disease Notification System, United States, 2009.","volume":"62","author":"Lee","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R31","unstructured":"CDC. Understanding the TB cohort review process: instruction guide. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. https:\/\/www.cdc.gov\/tb\/education\/cohort.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R32","unstructured":"CDC. TB program evaluation handbook. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. https:\/\/www.cdc.gov\/tb\/programs\/evaluation\/tbevaluationhandbook_tagged.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R33","unstructured":"CDC. TB Program Evaluation Network. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. http:\/\/tbpen.pbworks.com\/w\/page\/4124488\/FrontPage"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R34","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1473-3099(17)30248-7","article-title":"Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.","volume":"17","author":"LoBue","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R35","doi-asserted-by":"publisher","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis\u2014United States, 2011\u20132014.","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R36","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection.","volume":"49","author":"CDC","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children.","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R38","unstructured":"American Academy of Pediatrics. Tuberculosis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red book: 2018 report of the Committee on Infectious Diseases. 31st ed. Elk Grove Village, IL: American Academy of Pediatrics; 2018:831\u201355."},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R39","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010.","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R40","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection.","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/520983","article-title":"The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.","volume":"45","author":"Spyridis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R42","doi-asserted-by":"publisher","first-page":"CD007545","DOI":"10.1002\/14651858.CD007545.pub2","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.","volume":"2013","author":"Sharma","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R43","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R45","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020.","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R46","unstructured":"California Department of Public Health; California Tuberculosis Controllers Association. CDPH\/CTCA joint guidelines: TB case management core components. San Francisco, CA: California Tuberculosis Controllers Association; 2011. https:\/\/ctca.org\/wp-content\/uploads\/2018\/11\/ctca_case_management_5_.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R47","unstructured":"National Tuberculosis Controllers Association. Tuberculosis nursing: a comprehensive guide to patient care. Smyrna, GA: National Tuberculosis Controllers Association. http:\/\/www.tbcontrollers.org\/resources\/archives\/tb-nursing-manual"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R48","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis.","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R49","unstructured":"CDC. Treatment of tuberculosis disease [Chapter 6]. In: Core curriculum on tuberculosis: what the clinician should know. 6th ed. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. https:\/\/www.cdc.gov\/tb\/education\/corecurr\/pdf\/chapter6.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1164\/rccm.200401-095OC","article-title":"Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.","volume":"170","author":"Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.5588\/ijtld.15.0738","article-title":"Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.","volume":"20","author":"Chuck","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R52","unstructured":"Network for Public Health Law. Video directly observed therapy for tuberculosis: legal and practical issues. Edina, MN: Network for Public Health Law; 2016. https:\/\/www.health.state.mn.us\/diseases\/tb\/lph\/vdot\/nphlvdot.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R53","unstructured":"TB Centers of Excellence for Training, Education, and Medical Consultation [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/tb\/education\/tb_coe\/default.htm"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R54","unstructured":"CDC. Laboratory user guide for U.S. public health laboratories: molecular detection of drug resistance (MDDR) in\n                      Mycobacterium tuberculosis\n                      complex by DNA sequencing (Version 2.0). Atlanta, GA: US Department of Health and Human Services, CDC; 2012. https:\/\/www.cdc.gov\/tb\/topic\/laboratory\/mddrusersguide.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R55","unstructured":"Curry International Tuberculosis Center, California Department of Public Health. Drug-resistant tuberculosis: a survival guide for clinicians. 3rd ed. San Francisco, CA: Curry International Tuberculosis Center, California Department of Public Health; 2016. https:\/\/www.currytbcenter.ucsf.edu\/products\/view\/drug-resistant-tuberculosis-survival-guide-clinicians-3rd-edition"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R56","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis: an official ATS\/CDC\/ERS\/IDSA clinical practice guideline.","volume":"200","author":"Nahid","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R57","unstructured":"Thombley M, Stier D. Menu of suggested provisions for state tuberculosis prevention and control laws. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. http:\/\/tbcontrollers.org\/docs\/TBLawResources\/TBLawMenu1014.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R58","unstructured":"Santa Clara County Public Health Department. GOTCH law for inpatients at health care or correctional facilities. Sunnyvale, CA: Santa Clara County Public Health Department; 2019. https:\/\/www.sccgov.org\/sites\/phd-p\/Diseases\/TB\/Pages\/tb-home.aspx"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R59","unstructured":"Contra Costa Health Services. Tuberculosis information for providers. Martinez, CA: Contra Costa Health Services; 2020. https:\/\/cchealth.org\/tb\/providers.php"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R60","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.","volume":"54","author":"National Tuberculosis Controllers Association","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R61","unstructured":"CDC. Guide to the application of genotyping to tuberculosis prevention and control: handbook for TB controllers, epidemiologists, laboratorians, and other program staff. Atlanta, GA: US Department of Health and Human Services, CDC; 2004. https:\/\/www.cdc.gov\/tb\/programs\/genotyping\/images\/TBGenotypingGuide_June2004.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R62","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1128\/JCM.00567-14","article-title":"Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach.","volume":"52","author":"Kohl","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R63","unstructured":"Curry FJ. Patients\u2019 charter for tuberculosis care. San Francisco, CA: World Care Council; 2006. https:\/\/www.who.int\/tb\/publications\/2006\/istc_charter.pdf"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1471-2334-14-281","article-title":"Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.","volume":"14","author":"Adams","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R65","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archinte.162.9.1044","article-title":"Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail.","volume":"162","author":"White","year":"2002","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R66","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling.","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"key-10.15585\/mmwr.rr6907a1-202007301025-R67","unstructured":"Tuberculosis Research: TB Epidemiologic Studies Consortium [Internet]. Atlanta, GA: US Department of Health and Human Services; CDC; 2016. https:\/\/www.cdc.gov\/tb\/topic\/research\/default.htm"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T10:29:41Z","timestamp":1596104981000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6907a1.htm?s_cid=rr6907a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,31]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6907a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7,31]]},"published":{"date-parts":[[2020,7,31]]}}}